Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma | 28 | 2024 | 1899 | 3.180 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 20 | 2020 | 180 | 2.110 |
Why?
|
Lymphoproliferative Disorders | 21 | 2024 | 533 | 2.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 21 | 2024 | 1401 | 1.790 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 6 | 2022 | 167 | 1.460 |
Why?
|
Lymphoma, T-Cell | 12 | 2024 | 305 | 1.340 |
Why?
|
Lymphoma, B-Cell | 22 | 2024 | 935 | 1.340 |
Why?
|
Testicular Neoplasms | 10 | 2019 | 800 | 1.270 |
Why?
|
Immunoglobulin G | 12 | 2021 | 4546 | 1.250 |
Why?
|
Lymphoma, Follicular | 12 | 2024 | 453 | 1.100 |
Why?
|
Histiocytosis, Sinus | 3 | 2024 | 46 | 1.090 |
Why?
|
World Health Organization | 8 | 2024 | 1319 | 1.040 |
Why?
|
Hodgkin Disease | 13 | 2018 | 1381 | 1.030 |
Why?
|
Retroperitoneal Fibrosis | 1 | 2024 | 41 | 0.950 |
Why?
|
Antigens, CD20 | 5 | 2018 | 201 | 0.940 |
Why?
|
Immunophenotyping | 33 | 2019 | 1870 | 0.930 |
Why?
|
Epstein-Barr Virus Infections | 9 | 2023 | 608 | 0.870 |
Why?
|
Osteolysis | 1 | 2024 | 274 | 0.830 |
Why?
|
Lymphoma, T-Cell, Peripheral | 5 | 2014 | 124 | 0.830 |
Why?
|
Neoplasms, Plasma Cell | 2 | 2024 | 39 | 0.810 |
Why?
|
Diagnosis, Differential | 46 | 2024 | 12968 | 0.790 |
Why?
|
Plasma Cells | 10 | 2021 | 592 | 0.780 |
Why?
|
Herpesviridae Infections | 3 | 2014 | 270 | 0.770 |
Why?
|
Hereditary Autoinflammatory Diseases | 1 | 2022 | 42 | 0.770 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2022 | 1628 | 0.680 |
Why?
|
Hematologic Neoplasms | 5 | 2024 | 1899 | 0.680 |
Why?
|
Lymph Nodes | 16 | 2024 | 3491 | 0.650 |
Why?
|
Central Nervous System Neoplasms | 4 | 2020 | 917 | 0.640 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2021 | 266 | 0.630 |
Why?
|
Pleural Effusion | 1 | 2022 | 343 | 0.630 |
Why?
|
Dacryocystitis | 2 | 2016 | 68 | 0.630 |
Why?
|
Orbital Pseudotumor | 2 | 2015 | 42 | 0.610 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2022 | 378 | 0.600 |
Why?
|
Immunohistochemistry | 32 | 2021 | 11064 | 0.600 |
Why?
|
Gene Rearrangement | 9 | 2018 | 1122 | 0.590 |
Why?
|
Hematologic Diseases | 1 | 2021 | 497 | 0.570 |
Why?
|
Lymphoma, Large-Cell, Immunoblastic | 2 | 2009 | 25 | 0.550 |
Why?
|
Autoimmune Diseases | 5 | 2015 | 2250 | 0.520 |
Why?
|
Herpesvirus 4, Human | 11 | 2023 | 1075 | 0.520 |
Why?
|
Orbital Neoplasms | 6 | 2009 | 221 | 0.500 |
Why?
|
Immune System Diseases | 1 | 2017 | 258 | 0.500 |
Why?
|
Sialadenitis | 2 | 2012 | 45 | 0.500 |
Why?
|
Kidney | 3 | 2024 | 7072 | 0.490 |
Why?
|
Vision Disorders | 1 | 2022 | 1084 | 0.490 |
Why?
|
Consensus | 1 | 2024 | 3106 | 0.470 |
Why?
|
Bone Marrow | 6 | 2021 | 2918 | 0.460 |
Why?
|
Head and Neck Neoplasms | 4 | 2022 | 2880 | 0.460 |
Why?
|
Lymphatic Diseases | 5 | 2009 | 319 | 0.450 |
Why?
|
Eye Neoplasms | 2 | 2007 | 306 | 0.440 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 3 | 2024 | 45 | 0.430 |
Why?
|
Herpesvirus 8, Human | 3 | 2014 | 255 | 0.430 |
Why?
|
Mediastinal Neoplasms | 4 | 2016 | 402 | 0.420 |
Why?
|
Burkitt Lymphoma | 3 | 2016 | 333 | 0.410 |
Why?
|
Organ Transplantation | 7 | 2024 | 1150 | 0.390 |
Why?
|
Lymphoma, Mantle-Cell | 4 | 2018 | 237 | 0.380 |
Why?
|
Conjunctival Neoplasms | 3 | 2007 | 77 | 0.370 |
Why?
|
Biopsy | 19 | 2024 | 6775 | 0.370 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 2 | 2021 | 30 | 0.360 |
Why?
|
Orbital Diseases | 1 | 2012 | 178 | 0.360 |
Why?
|
Humans | 183 | 2024 | 760261 | 0.360 |
Why?
|
Fatal Outcome | 10 | 2014 | 1833 | 0.350 |
Why?
|
Middle Aged | 107 | 2024 | 220175 | 0.340 |
Why?
|
Breast Implants | 3 | 2019 | 411 | 0.340 |
Why?
|
Orchitis | 1 | 2009 | 35 | 0.340 |
Why?
|
Lymphoma, Non-Hodgkin | 6 | 2003 | 1378 | 0.330 |
Why?
|
Aged | 89 | 2022 | 168995 | 0.330 |
Why?
|
Amyloid | 2 | 2012 | 843 | 0.320 |
Why?
|
Male | 108 | 2024 | 359413 | 0.310 |
Why?
|
Aged, 80 and over | 46 | 2021 | 58947 | 0.310 |
Why?
|
Paranasal Sinus Neoplasms | 3 | 2016 | 241 | 0.310 |
Why?
|
Pathology | 2 | 2008 | 270 | 0.300 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2008 | 255 | 0.290 |
Why?
|
Immunoglobulin Heavy Chains | 5 | 2016 | 649 | 0.290 |
Why?
|
Epididymis | 3 | 2007 | 228 | 0.290 |
Why?
|
Amyloidosis | 2 | 2012 | 818 | 0.290 |
Why?
|
Killer Cells, Natural | 5 | 2024 | 2204 | 0.280 |
Why?
|
Female | 116 | 2024 | 391011 | 0.280 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2014 | 1765 | 0.280 |
Why?
|
Chromosome Aberrations | 6 | 2023 | 1767 | 0.270 |
Why?
|
Leukemia | 6 | 2019 | 1522 | 0.270 |
Why?
|
Plasmacytoma | 4 | 2000 | 171 | 0.270 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2020 | 698 | 0.270 |
Why?
|
Adult | 88 | 2022 | 219847 | 0.270 |
Why?
|
Cyclin D2 | 2 | 2018 | 98 | 0.270 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2007 | 72 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 6 | 2024 | 1408 | 0.260 |
Why?
|
Germinal Center | 4 | 2017 | 379 | 0.250 |
Why?
|
Pseudolymphoma | 3 | 2014 | 30 | 0.250 |
Why?
|
Lymphoid Tissue | 7 | 2013 | 446 | 0.250 |
Why?
|
Leukemia, Myeloid | 5 | 2005 | 696 | 0.230 |
Why?
|
Duodenal Neoplasms | 1 | 2004 | 113 | 0.230 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2024 | 34 | 0.230 |
Why?
|
Skin Neoplasms | 11 | 2019 | 5797 | 0.230 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 951 | 0.220 |
Why?
|
Azetidines | 1 | 2024 | 137 | 0.220 |
Why?
|
Nose Neoplasms | 3 | 2003 | 249 | 0.220 |
Why?
|
Virus Diseases | 1 | 2009 | 721 | 0.220 |
Why?
|
Ovary | 1 | 2008 | 959 | 0.220 |
Why?
|
Vasculitis | 1 | 2007 | 523 | 0.220 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2004 | 586 | 0.220 |
Why?
|
T-Lymphocytes | 8 | 2024 | 10183 | 0.210 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2024 | 332 | 0.210 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2002 | 40 | 0.210 |
Why?
|
Translocation, Genetic | 7 | 2024 | 1388 | 0.210 |
Why?
|
Interferon Regulatory Factors | 3 | 2016 | 260 | 0.210 |
Why?
|
Cyclin D1 | 3 | 2018 | 453 | 0.210 |
Why?
|
In Situ Hybridization, Fluorescence | 9 | 2022 | 2500 | 0.210 |
Why?
|
Uterine Cervical Neoplasms | 7 | 2000 | 2018 | 0.210 |
Why?
|
Histiocytosis | 1 | 2022 | 40 | 0.200 |
Why?
|
Immunoenzyme Techniques | 12 | 2010 | 1705 | 0.200 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2003 | 164 | 0.200 |
Why?
|
Sclerosis | 4 | 2015 | 210 | 0.200 |
Why?
|
HIV Seropositivity | 1 | 2007 | 955 | 0.200 |
Why?
|
Polymyalgia Rheumatica | 1 | 2022 | 53 | 0.200 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2009 | 2197 | 0.200 |
Why?
|
Erythrocytes, Abnormal | 1 | 2022 | 121 | 0.190 |
Why?
|
Flow Cytometry | 7 | 2014 | 5873 | 0.190 |
Why?
|
Cyclin D3 | 2 | 2018 | 54 | 0.190 |
Why?
|
Exanthema | 4 | 2009 | 504 | 0.190 |
Why?
|
Helicobacter Infections | 1 | 2004 | 386 | 0.180 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2022 | 1614 | 0.180 |
Why?
|
In Situ Hybridization | 8 | 2014 | 1900 | 0.180 |
Why?
|
Recurrence | 6 | 2022 | 8487 | 0.180 |
Why?
|
Stomach Neoplasms | 4 | 2009 | 1423 | 0.170 |
Why?
|
Education | 2 | 2019 | 535 | 0.170 |
Why?
|
Immunoglobulin Light Chains | 2 | 2018 | 278 | 0.170 |
Why?
|
Tonsillar Neoplasms | 1 | 2020 | 50 | 0.170 |
Why?
|
Colic | 1 | 2019 | 44 | 0.160 |
Why?
|
Antigens, CD19 | 2 | 2022 | 414 | 0.160 |
Why?
|
Nephrectomy | 1 | 2024 | 1017 | 0.160 |
Why?
|
Breast | 1 | 2008 | 1980 | 0.160 |
Why?
|
Central Nervous System | 2 | 2022 | 1334 | 0.160 |
Why?
|
Treponema pallidum | 1 | 2018 | 47 | 0.150 |
Why?
|
Gastrointestinal Tract | 3 | 2019 | 830 | 0.150 |
Why?
|
Neoplasm Staging | 16 | 2011 | 11141 | 0.150 |
Why?
|
Syndrome | 3 | 2022 | 3278 | 0.150 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2019 | 209 | 0.140 |
Why?
|
Neck | 1 | 2022 | 730 | 0.140 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3613 | 0.140 |
Why?
|
Nasal Cavity | 2 | 2003 | 304 | 0.140 |
Why?
|
Fever | 3 | 2010 | 1618 | 0.140 |
Why?
|
Adolescent | 36 | 2024 | 87747 | 0.140 |
Why?
|
Myeloproliferative Disorders | 1 | 2003 | 612 | 0.140 |
Why?
|
Neural Tube Defects | 1 | 1999 | 254 | 0.140 |
Why?
|
Polymerase Chain Reaction | 8 | 2011 | 6067 | 0.140 |
Why?
|
Infectious Mononucleosis | 2 | 2012 | 133 | 0.140 |
Why?
|
Lymphocytes | 4 | 2014 | 2612 | 0.140 |
Why?
|
Bone Marrow Examination | 4 | 2009 | 155 | 0.140 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1997 | 118 | 0.140 |
Why?
|
Ampulla of Vater | 1 | 1997 | 147 | 0.140 |
Why?
|
Child | 26 | 2024 | 79758 | 0.130 |
Why?
|
S100 Proteins | 2 | 2014 | 218 | 0.130 |
Why?
|
Skin Diseases | 2 | 2015 | 1089 | 0.130 |
Why?
|
Prognosis | 17 | 2024 | 29636 | 0.130 |
Why?
|
Receptors, Cholinergic | 1 | 2017 | 244 | 0.130 |
Why?
|
Sarcoma | 2 | 2021 | 1786 | 0.130 |
Why?
|
Piperidines | 1 | 2024 | 1650 | 0.130 |
Why?
|
Karyotyping | 4 | 2010 | 1172 | 0.130 |
Why?
|
Young Adult | 18 | 2021 | 58673 | 0.130 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2016 | 1539 | 0.130 |
Why?
|
Mouth | 1 | 2018 | 380 | 0.130 |
Why?
|
Syphilis | 1 | 2018 | 240 | 0.130 |
Why?
|
Blotting, Southern | 3 | 2011 | 778 | 0.120 |
Why?
|
Radiography, Thoracic | 1 | 2022 | 1295 | 0.120 |
Why?
|
Cytogenetic Analysis | 4 | 2023 | 271 | 0.120 |
Why?
|
Breast Implantation | 1 | 2018 | 223 | 0.120 |
Why?
|
Mastocytosis, Systemic | 1 | 2016 | 102 | 0.120 |
Why?
|
Down Syndrome | 1 | 2003 | 891 | 0.120 |
Why?
|
Myasthenia Gravis | 2 | 2017 | 213 | 0.120 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2007 | 2160 | 0.120 |
Why?
|
Liver | 2 | 2009 | 7512 | 0.120 |
Why?
|
Carcinoma, Adenoid Cystic | 3 | 1997 | 262 | 0.120 |
Why?
|
Survival Rate | 9 | 2017 | 12806 | 0.120 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2019 | 581 | 0.120 |
Why?
|
Tuberculosis, Miliary | 1 | 2014 | 13 | 0.120 |
Why?
|
Mutation | 6 | 2024 | 29950 | 0.120 |
Why?
|
Splenic Neoplasms | 1 | 2015 | 96 | 0.120 |
Why?
|
Spermatic Cord | 1 | 1994 | 24 | 0.120 |
Why?
|
B-Lymphocytes | 6 | 2001 | 4739 | 0.120 |
Why?
|
Fibrin | 1 | 2017 | 505 | 0.120 |
Why?
|
Sertoli Cell Tumor | 1 | 1994 | 36 | 0.120 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 1994 | 59 | 0.120 |
Why?
|
Disease-Free Survival | 5 | 2016 | 6830 | 0.120 |
Why?
|
Genetic Loci | 2 | 2015 | 2618 | 0.110 |
Why?
|
Cholestasis | 1 | 1997 | 374 | 0.110 |
Why?
|
Glucocorticoids | 2 | 2022 | 2143 | 0.110 |
Why?
|
Genital Neoplasms, Male | 1 | 1994 | 68 | 0.110 |
Why?
|
Colonic Polyps | 1 | 2019 | 550 | 0.110 |
Why?
|
Perforin | 1 | 2014 | 167 | 0.110 |
Why?
|
Skin | 1 | 2007 | 4468 | 0.110 |
Why?
|
Sjogren's Syndrome | 2 | 2012 | 235 | 0.110 |
Why?
|
Predictive Value of Tests | 8 | 2018 | 15273 | 0.110 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 2010 | 91 | 0.110 |
Why?
|
Mast-Cell Sarcoma | 1 | 2012 | 46 | 0.110 |
Why?
|
Biological Products | 1 | 2022 | 914 | 0.110 |
Why?
|
Reed-Sternberg Cells | 2 | 2012 | 72 | 0.110 |
Why?
|
Sulfonamides | 1 | 2022 | 1973 | 0.100 |
Why?
|
Remission Induction | 4 | 2017 | 2394 | 0.100 |
Why?
|
Cervix Uteri | 2 | 2000 | 585 | 0.100 |
Why?
|
Deglutition Disorders | 2 | 2009 | 627 | 0.100 |
Why?
|
Granzymes | 1 | 2014 | 276 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1293 | 0.100 |
Why?
|
Combined Modality Therapy | 9 | 2008 | 8551 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 6 | 2024 | 20484 | 0.100 |
Why?
|
Antigens, CD1 | 1 | 2014 | 439 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1356 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2015 | 1790 | 0.100 |
Why?
|
Intestinal Diseases | 1 | 2016 | 507 | 0.100 |
Why?
|
Hypergammaglobulinemia | 1 | 2011 | 72 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2014 | 2823 | 0.100 |
Why?
|
Carcinoma in Situ | 2 | 1995 | 796 | 0.100 |
Why?
|
Orbital Myositis | 1 | 2011 | 25 | 0.100 |
Why?
|
Mesonephroma | 1 | 1990 | 21 | 0.090 |
Why?
|
Mesonephros | 1 | 1990 | 41 | 0.090 |
Why?
|
Eosinophilic Granuloma | 1 | 1991 | 27 | 0.090 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2011 | 49 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2016 | 593 | 0.090 |
Why?
|
DNA-Binding Proteins | 7 | 2011 | 9590 | 0.090 |
Why?
|
Terminology as Topic | 3 | 2014 | 1534 | 0.090 |
Why?
|
Treatment Outcome | 16 | 2018 | 64947 | 0.090 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 2 | 2009 | 112 | 0.090 |
Why?
|
Lymphocytosis | 1 | 2011 | 119 | 0.090 |
Why?
|
Submandibular Gland Diseases | 1 | 2010 | 22 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 5 | 2014 | 191 | 0.090 |
Why?
|
Genital Neoplasms, Female | 2 | 1997 | 538 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1189 | 0.090 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 57 | 0.090 |
Why?
|
Antibodies, Neoplasm | 2 | 2009 | 280 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8498 | 0.090 |
Why?
|
Parotid Diseases | 1 | 2010 | 49 | 0.090 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2009 | 23 | 0.090 |
Why?
|
Codon | 1 | 2011 | 602 | 0.090 |
Why?
|
Candidiasis, Oral | 1 | 2009 | 57 | 0.080 |
Why?
|
Bone Marrow Diseases | 1 | 1991 | 233 | 0.080 |
Why?
|
Uterine Cervical Diseases | 1 | 2010 | 74 | 0.080 |
Why?
|
Monocytes | 1 | 1999 | 2574 | 0.080 |
Why?
|
Ki-67 Antigen | 2 | 2012 | 631 | 0.080 |
Why?
|
Receptors, Complement 3d | 2 | 2007 | 117 | 0.080 |
Why?
|
Lipoma | 1 | 1991 | 292 | 0.080 |
Why?
|
Paraproteinemias | 1 | 2012 | 246 | 0.080 |
Why?
|
Genital Diseases, Female | 1 | 1991 | 191 | 0.080 |
Why?
|
Radiotherapy | 2 | 2008 | 1505 | 0.080 |
Why?
|
Follow-Up Studies | 15 | 2017 | 39254 | 0.080 |
Why?
|
Telepathology | 1 | 2009 | 77 | 0.080 |
Why?
|
Genes, T-Cell Receptor gamma | 1 | 2008 | 15 | 0.080 |
Why?
|
Hyperplasia | 6 | 1999 | 1158 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2874 | 0.080 |
Why?
|
Uterine Diseases | 1 | 2010 | 117 | 0.080 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2008 | 71 | 0.080 |
Why?
|
Failure to Thrive | 1 | 2009 | 140 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2015 | 3531 | 0.080 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 169 | 0.080 |
Why?
|
Mycoses | 1 | 1991 | 387 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2017 | 2536 | 0.080 |
Why?
|
Intestinal Neoplasms | 1 | 2010 | 311 | 0.080 |
Why?
|
Uterine Neoplasms | 3 | 1995 | 1434 | 0.080 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5644 | 0.070 |
Why?
|
Carcinoma | 2 | 1997 | 2334 | 0.070 |
Why?
|
Intestinal Obstruction | 1 | 2011 | 435 | 0.070 |
Why?
|
Radiography | 3 | 2007 | 6965 | 0.070 |
Why?
|
Multiple Myeloma | 3 | 2010 | 5131 | 0.070 |
Why?
|
Mediastinal Diseases | 1 | 2008 | 91 | 0.070 |
Why?
|
Orchiectomy | 1 | 2009 | 470 | 0.070 |
Why?
|
Megakaryocytes | 1 | 1991 | 566 | 0.070 |
Why?
|
Liver Transplantation | 3 | 2002 | 2317 | 0.070 |
Why?
|
Bone Neoplasms | 2 | 2017 | 2532 | 0.070 |
Why?
|
Remote Consultation | 1 | 2009 | 234 | 0.070 |
Why?
|
Hospitals, General | 1 | 2011 | 795 | 0.070 |
Why?
|
Weight Loss | 2 | 2009 | 2683 | 0.070 |
Why?
|
Endometrial Neoplasms | 1 | 2016 | 1361 | 0.070 |
Why?
|
Splenomegaly | 1 | 2007 | 189 | 0.070 |
Why?
|
Syndecan-1 | 1 | 2007 | 163 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2015 | 11708 | 0.070 |
Why?
|
Postoperative Complications | 4 | 2024 | 15680 | 0.070 |
Why?
|
Time Factors | 6 | 2015 | 40133 | 0.070 |
Why?
|
Transcription Factors | 5 | 2011 | 12100 | 0.070 |
Why?
|
Kidney Neoplasms | 2 | 1995 | 4312 | 0.070 |
Why?
|
Hemangioma | 1 | 1991 | 727 | 0.070 |
Why?
|
Lymphocyte Activation | 2 | 2014 | 5498 | 0.070 |
Why?
|
Hypertriglyceridemia | 1 | 2010 | 316 | 0.070 |
Why?
|
SOXC Transcription Factors | 2 | 2018 | 41 | 0.070 |
Why?
|
Digestive System Surgical Procedures | 1 | 2011 | 576 | 0.070 |
Why?
|
Crohn Disease | 1 | 2019 | 2275 | 0.070 |
Why?
|
Blood Chemical Analysis | 1 | 2008 | 437 | 0.070 |
Why?
|
Pathology, Clinical | 1 | 2009 | 375 | 0.070 |
Why?
|
Gallbladder | 1 | 2007 | 305 | 0.070 |
Why?
|
Antibodies, Antinuclear | 1 | 2007 | 344 | 0.070 |
Why?
|
Antigens, Neoplasm | 4 | 2010 | 1999 | 0.060 |
Why?
|
Ultrasonography, Mammary | 1 | 2008 | 247 | 0.060 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2009 | 661 | 0.060 |
Why?
|
Antigens, CD | 7 | 2012 | 4002 | 0.060 |
Why?
|
Survival Analysis | 5 | 2016 | 10185 | 0.060 |
Why?
|
Spinal Cord Neoplasms | 1 | 1988 | 264 | 0.060 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1988 | 545 | 0.060 |
Why?
|
Phototherapy | 1 | 2008 | 367 | 0.060 |
Why?
|
Tachycardia | 1 | 2008 | 603 | 0.060 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2005 | 228 | 0.060 |
Why?
|
Cystadenocarcinoma, Papillary | 2 | 1995 | 57 | 0.060 |
Why?
|
Salivary Gland Neoplasms | 1 | 2009 | 304 | 0.060 |
Why?
|
Breast Diseases | 1 | 2008 | 443 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2009 | 5793 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 995 | 0.060 |
Why?
|
Neprilysin | 3 | 2001 | 472 | 0.060 |
Why?
|
Neoplasms | 2 | 2024 | 22066 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2012 | 10434 | 0.060 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 1984 | 46 | 0.060 |
Why?
|
Kidney Transplantation | 3 | 2002 | 4215 | 0.060 |
Why?
|
Lupus Nephritis | 1 | 2007 | 318 | 0.060 |
Why?
|
Hypotension | 1 | 2010 | 883 | 0.060 |
Why?
|
Leiomyoma | 1 | 1989 | 654 | 0.060 |
Why?
|
Edema | 1 | 2008 | 772 | 0.060 |
Why?
|
Chromosomes, Human, X | 1 | 2005 | 320 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2022 | 9274 | 0.050 |
Why?
|
Rectum | 1 | 2008 | 896 | 0.050 |
Why?
|
Blast Crisis | 1 | 2003 | 101 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2022 | 80301 | 0.050 |
Why?
|
Neurilemmoma | 1 | 1988 | 523 | 0.050 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 13629 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2008 | 830 | 0.050 |
Why?
|
Gastritis | 1 | 2004 | 198 | 0.050 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 2 | 1994 | 317 | 0.050 |
Why?
|
Lung | 4 | 2009 | 9989 | 0.050 |
Why?
|
Dendritic Cells | 3 | 2021 | 2730 | 0.050 |
Why?
|
Leukocytosis | 1 | 2003 | 251 | 0.050 |
Why?
|
Gene Deletion | 1 | 2009 | 2668 | 0.050 |
Why?
|
Thromboembolism | 1 | 1988 | 1016 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 1995 | 4024 | 0.050 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2003 | 881 | 0.050 |
Why?
|
DNA, Viral | 4 | 2023 | 2195 | 0.050 |
Why?
|
Boston | 2 | 2011 | 9282 | 0.050 |
Why?
|
Genes, myc | 2 | 2014 | 395 | 0.050 |
Why?
|
Leukocyte Count | 2 | 2003 | 1600 | 0.050 |
Why?
|
Thymus Gland | 2 | 2004 | 1246 | 0.050 |
Why?
|
Hyperparathyroidism | 1 | 1983 | 339 | 0.050 |
Why?
|
Helicobacter pylori | 1 | 2004 | 377 | 0.050 |
Why?
|
Mesoderm | 1 | 2024 | 671 | 0.050 |
Why?
|
Gene Dosage | 2 | 2019 | 1218 | 0.050 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 1121 | 0.050 |
Why?
|
Child, Preschool | 11 | 2024 | 42034 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 2018 | 21065 | 0.050 |
Why?
|
Multiple Organ Failure | 1 | 2003 | 387 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2001 | 4494 | 0.040 |
Why?
|
Chemoprevention | 1 | 2022 | 326 | 0.040 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2015 | 693 | 0.040 |
Why?
|
Hypercalcemia | 1 | 2003 | 421 | 0.040 |
Why?
|
Mosaicism | 1 | 2003 | 466 | 0.040 |
Why?
|
Keratins | 2 | 1994 | 497 | 0.040 |
Why?
|
Radiotherapy Dosage | 2 | 2003 | 2897 | 0.040 |
Why?
|
Dyspnea | 1 | 2008 | 1352 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2007 | 2424 | 0.040 |
Why?
|
Oncogene Fusion | 1 | 2019 | 81 | 0.040 |
Why?
|
Uveal Neoplasms | 1 | 2002 | 339 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2017 | 8984 | 0.040 |
Why?
|
Disease Progression | 4 | 2012 | 13505 | 0.040 |
Why?
|
Ovarian Neoplasms | 2 | 1997 | 4875 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 2 | 2010 | 473 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5784 | 0.040 |
Why?
|
Eye Diseases | 1 | 2003 | 651 | 0.040 |
Why?
|
Biopsy, Needle | 2 | 2014 | 1633 | 0.040 |
Why?
|
Digestive System | 1 | 2019 | 244 | 0.040 |
Why?
|
Spleen | 1 | 2024 | 2298 | 0.040 |
Why?
|
Conjunctivitis | 1 | 1999 | 155 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2015 | 6545 | 0.040 |
Why?
|
Interleukin-18 | 1 | 1999 | 251 | 0.040 |
Why?
|
Chemokines, CXC | 1 | 1999 | 421 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2005 | 1591 | 0.040 |
Why?
|
RNA, Viral | 3 | 2014 | 2837 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4357 | 0.040 |
Why?
|
Diagnostic Errors | 2 | 2018 | 1266 | 0.040 |
Why?
|
Phenotype | 2 | 2014 | 16543 | 0.040 |
Why?
|
Contact Tracing | 1 | 1999 | 268 | 0.040 |
Why?
|
Cell Count | 3 | 2014 | 1838 | 0.040 |
Why?
|
Mammography | 1 | 2008 | 2452 | 0.030 |
Why?
|
Bacteriological Techniques | 1 | 2018 | 279 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 23363 | 0.030 |
Why?
|
Bone Marrow Transplantation | 2 | 2010 | 2696 | 0.030 |
Why?
|
Skull Neoplasms | 1 | 1997 | 173 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9196 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2861 | 0.030 |
Why?
|
Heart Transplantation | 1 | 1989 | 3217 | 0.030 |
Why?
|
Lymphomatoid Papulosis | 1 | 2015 | 16 | 0.030 |
Why?
|
DNA, Neoplasm | 4 | 2010 | 1745 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1828 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3526 | 0.030 |
Why?
|
DNA Methylation | 1 | 2009 | 4374 | 0.030 |
Why?
|
Clone Cells | 3 | 2010 | 1663 | 0.030 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2015 | 44 | 0.030 |
Why?
|
Immunologic Factors | 2 | 2017 | 1589 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2004 | 2007 | 0.030 |
Why?
|
Bone Marrow Neoplasms | 1 | 1996 | 101 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2010 | 867 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2003 | 1402 | 0.030 |
Why?
|
Transplantation Chimera | 1 | 2017 | 595 | 0.030 |
Why?
|
Tissue Donors | 2 | 1995 | 2314 | 0.030 |
Why?
|
United States | 4 | 2018 | 72363 | 0.030 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2020 | 491 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2004 | 2633 | 0.030 |
Why?
|
Receptors, Interleukin-2 | 1 | 1995 | 562 | 0.030 |
Why?
|
Specimen Handling | 1 | 1999 | 708 | 0.030 |
Why?
|
Tongue Neoplasms | 1 | 1996 | 183 | 0.030 |
Why?
|
Viral Load | 1 | 2023 | 3323 | 0.030 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 1 | 1993 | 22 | 0.030 |
Why?
|
Vimentin | 1 | 1994 | 255 | 0.030 |
Why?
|
Genes, Immunoglobulin | 1 | 1994 | 287 | 0.030 |
Why?
|
Europe | 2 | 2016 | 3433 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 1990 | 6310 | 0.030 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1999 | 832 | 0.030 |
Why?
|
Prednisone | 2 | 2011 | 1566 | 0.030 |
Why?
|
Infant, Newborn | 5 | 2012 | 26168 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1442 | 0.030 |
Why?
|
Carcinoma, Small Cell | 2 | 2000 | 416 | 0.030 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 1994 | 113 | 0.030 |
Why?
|
Transplantation, Homologous | 3 | 2001 | 4814 | 0.030 |
Why?
|
Genes, T-Cell Receptor | 1 | 2011 | 30 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1999 | 1349 | 0.020 |
Why?
|
Lung Neoplasms | 3 | 2009 | 13249 | 0.020 |
Why?
|
Prostate | 1 | 2000 | 1793 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 1999 | 1655 | 0.020 |
Why?
|
Cryptococcus | 1 | 1991 | 28 | 0.020 |
Why?
|
Thymoma | 1 | 1993 | 187 | 0.020 |
Why?
|
Histoplasma | 1 | 1991 | 39 | 0.020 |
Why?
|
Pathology, Molecular | 1 | 2014 | 330 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2024 | 4168 | 0.020 |
Why?
|
Papillomaviridae | 1 | 1997 | 1117 | 0.020 |
Why?
|
Maryland | 1 | 2011 | 275 | 0.020 |
Why?
|
Histiocytes | 1 | 1991 | 98 | 0.020 |
Why?
|
Chronic Disease | 3 | 2017 | 9283 | 0.020 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 111 | 0.020 |
Why?
|
Thymus Neoplasms | 1 | 1993 | 274 | 0.020 |
Why?
|
Vulvar Neoplasms | 1 | 1993 | 265 | 0.020 |
Why?
|
Exophthalmos | 1 | 2011 | 97 | 0.020 |
Why?
|
Peru | 1 | 1993 | 870 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2003 | 2469 | 0.020 |
Why?
|
Melanoma | 3 | 2002 | 5695 | 0.020 |
Why?
|
North America | 1 | 2014 | 1282 | 0.020 |
Why?
|
NF-kappa B | 1 | 2019 | 2486 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1991 | 282 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 670 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2011 | 492 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4127 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 410 | 0.020 |
Why?
|
Reference Values | 3 | 2010 | 4920 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1447 | 0.020 |
Why?
|
Genotype | 3 | 1993 | 12959 | 0.020 |
Why?
|
Pregnancy | 3 | 2008 | 29725 | 0.020 |
Why?
|
Atrophy | 1 | 2014 | 1625 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1601 | 0.020 |
Why?
|
Macrophage Activation Syndrome | 1 | 2010 | 123 | 0.020 |
Why?
|
Interphase | 1 | 2009 | 228 | 0.020 |
Why?
|
Venules | 1 | 1988 | 164 | 0.020 |
Why?
|
Pathology, Surgical | 1 | 2009 | 151 | 0.020 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 2 | 2001 | 40 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2010 | 551 | 0.020 |
Why?
|
Necrosis | 1 | 2012 | 1612 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2009 | 375 | 0.020 |
Why?
|
Transplantation Immunology | 1 | 1989 | 532 | 0.020 |
Why?
|
Infant | 5 | 2012 | 36030 | 0.020 |
Why?
|
Staining and Labeling | 1 | 1991 | 1090 | 0.020 |
Why?
|
Cytoplasm | 1 | 1991 | 1518 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 1997 | 1401 | 0.020 |
Why?
|
Paraganglioma | 1 | 1988 | 142 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2042 | 0.020 |
Why?
|
Carcinoid Tumor | 1 | 1988 | 228 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 1988 | 336 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2017 | 22041 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1994 | 1811 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20048 | 0.020 |
Why?
|
Age Factors | 2 | 2014 | 18415 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2007 | 11891 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 7400 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2927 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4573 | 0.020 |
Why?
|
Capillaries | 1 | 1988 | 745 | 0.020 |
Why?
|
Liver Neoplasms | 2 | 2009 | 4317 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2009 | 12281 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5790 | 0.020 |
Why?
|
Spine | 1 | 1992 | 1111 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2508 | 0.020 |
Why?
|
Laryngeal Neoplasms | 1 | 1988 | 514 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2932 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2009 | 1493 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4109 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5039 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2012 | 2008 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1134 | 0.010 |
Why?
|
Shoulder Joint | 1 | 1990 | 730 | 0.010 |
Why?
|
Demyelinating Diseases | 1 | 1986 | 351 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2646 | 0.010 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 1983 | 25 | 0.010 |
Why?
|
Cartilage, Articular | 1 | 1990 | 1091 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2010 | 1548 | 0.010 |
Why?
|
Mucin-1 | 1 | 1988 | 539 | 0.010 |
Why?
|
Chromosome Mapping | 2 | 2005 | 4625 | 0.010 |
Why?
|
HIV Infections | 1 | 2009 | 17159 | 0.010 |
Why?
|
RNA, Nuclear | 1 | 2002 | 30 | 0.010 |
Why?
|
Patient Admission | 1 | 2010 | 1384 | 0.010 |
Why?
|
Risk Assessment | 2 | 2016 | 24086 | 0.010 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1988 | 938 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2009 | 36247 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4091 | 0.010 |
Why?
|
Gammaherpesvirinae | 1 | 2001 | 27 | 0.010 |
Why?
|
Neuroectodermal Tumor, Melanotic | 1 | 2000 | 3 | 0.010 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2000 | 36 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 1997 | 3606 | 0.010 |
Why?
|
Palatine Tonsil | 1 | 2001 | 193 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3774 | 0.010 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1986 | 708 | 0.010 |
Why?
|
North Dakota | 1 | 1999 | 14 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2002 | 900 | 0.010 |
Why?
|
Molecular Sequence Data | 3 | 2001 | 17628 | 0.010 |
Why?
|
Vincristine | 1 | 2002 | 1038 | 0.010 |
Why?
|
Chemokine CXCL9 | 1 | 1999 | 135 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2001 | 568 | 0.010 |
Why?
|
Tuberculin Test | 1 | 1999 | 206 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14482 | 0.010 |
Why?
|
Swine, Miniature | 1 | 2001 | 959 | 0.010 |
Why?
|
Chemokine CCL5 | 1 | 1999 | 214 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54263 | 0.010 |
Why?
|
Chemokine CXCL10 | 1 | 1999 | 316 | 0.010 |
Why?
|
Isoniazid | 1 | 1999 | 283 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1988 | 1647 | 0.010 |
Why?
|
Mucous Membrane | 2 | 1993 | 657 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12762 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10757 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1999 | 463 | 0.010 |
Why?
|
Vaginal Neoplasms | 1 | 1997 | 105 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 1988 | 3731 | 0.010 |
Why?
|
Emigration and Immigration | 1 | 1999 | 395 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2001 | 2178 | 0.010 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2000 | 387 | 0.010 |
Why?
|
General Surgery | 1 | 2008 | 1681 | 0.010 |
Why?
|
Laparotomy | 1 | 1999 | 468 | 0.010 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2000 | 487 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2002 | 2220 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1996 | 375 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2009 | 4938 | 0.010 |
Why?
|
Neoplasm Invasiveness | 2 | 1994 | 3618 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 2009 | 2332 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12532 | 0.010 |
Why?
|
Doxorubicin | 1 | 2002 | 2207 | 0.010 |
Why?
|
Cytodiagnosis | 1 | 1999 | 432 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5230 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 7268 | 0.010 |
Why?
|
Family Characteristics | 1 | 1999 | 1001 | 0.010 |
Why?
|
Models, Animal | 1 | 2001 | 2117 | 0.010 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1993 | 94 | 0.010 |
Why?
|
Molecular Probes | 1 | 1995 | 313 | 0.010 |
Why?
|
Base Sequence | 2 | 1995 | 12447 | 0.010 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 1993 | 142 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9388 | 0.010 |
Why?
|
Adenoma | 1 | 1983 | 2148 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15766 | 0.010 |
Why?
|
Rectal Neoplasms | 1 | 1981 | 1151 | 0.010 |
Why?
|
Brain | 2 | 2017 | 26912 | 0.010 |
Why?
|
Animals | 4 | 2011 | 167940 | 0.010 |
Why?
|
Aging | 1 | 1990 | 8641 | 0.010 |
Why?
|
Antitubercular Agents | 1 | 1999 | 1374 | 0.010 |
Why?
|
Schools | 1 | 1999 | 1474 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14656 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1994 | 2473 | 0.010 |
Why?
|
Immunoblotting | 1 | 1993 | 1649 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2000 | 4891 | 0.010 |
Why?
|
Cohort Studies | 1 | 2012 | 41317 | 0.010 |
Why?
|
Stomach Diseases | 1 | 1990 | 133 | 0.010 |
Why?
|
Ultrasonography | 1 | 2002 | 5960 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13456 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81216 | 0.000 |
Why?
|
Bronchial Neoplasms | 1 | 1989 | 110 | 0.000 |
Why?
|
Mycobacterium tuberculosis | 1 | 1999 | 1905 | 0.000 |
Why?
|
Tracheal Neoplasms | 1 | 1989 | 123 | 0.000 |
Why?
|
Ligaments, Articular | 1 | 1990 | 300 | 0.000 |
Why?
|
Meningioma | 1 | 1997 | 1220 | 0.000 |
Why?
|
Meningeal Neoplasms | 1 | 1997 | 1248 | 0.000 |
Why?
|
Stomach | 1 | 1990 | 695 | 0.000 |
Why?
|
Leukemia, Hairy Cell | 1 | 1986 | 83 | 0.000 |
Why?
|
Cell Division | 1 | 1993 | 4462 | 0.000 |
Why?
|
Hysterectomy | 1 | 1991 | 901 | 0.000 |
Why?
|
Bronchi | 1 | 1989 | 848 | 0.000 |
Why?
|
Blood Vessels | 1 | 1990 | 1112 | 0.000 |
Why?
|
Bacterial Vaccines | 1 | 1986 | 401 | 0.000 |
Why?
|
Fetus | 1 | 1990 | 1859 | 0.000 |
Why?
|
Trachea | 1 | 1989 | 1082 | 0.000 |
Why?
|
Mice, Transgenic | 1 | 1995 | 9531 | 0.000 |
Why?
|
Influenza A virus | 1 | 1986 | 457 | 0.000 |
Why?
|
Encephalitis | 1 | 1986 | 436 | 0.000 |
Why?
|
Pneumococcal Vaccines | 1 | 1986 | 397 | 0.000 |
Why?
|
Pneumonectomy | 1 | 1989 | 1110 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1990 | 2909 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1989 | 2945 | 0.000 |
Why?
|
Lipids | 1 | 1992 | 3336 | 0.000 |
Why?
|
Apoptosis | 1 | 1995 | 9497 | 0.000 |
Why?
|
Influenza Vaccines | 1 | 1986 | 770 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1995 | 11480 | 0.000 |
Why?
|
Macrophages | 1 | 1986 | 5745 | 0.000 |
Why?
|